Effects of Semaphorin 3A on Stroke Recovery
Semaphorin 3A 对中风恢复的影响
基本信息
- 批准号:8470260
- 负责人:
- 金额:$ 33.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:12-HETEAddressAffectAntibodiesArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseAxonBiological AssayBlood VesselsBrainBrain InjuriesBrain regionCell Culture TechniquesCell LineCellsCerebrumConfocal MicroscopyCorpus striatum structureDataEndothelial CellsEnvironmentGoalsGrowth ConesHealedHumanImmunohistochemistryIn VitroInfarctionInjuryIpsilateralIschemiaLeadLipoxygenaseMapsMediatingMediator of activation proteinMethodsMiddle Cerebral Artery OcclusionMitogen-Activated Protein KinasesModelingMolecularMusNeurofilament ProteinsNeuronsNeuropilin-1OutcomePathway interactionsProcessProteinsRecombinantsRecoveryRecovery of FunctionRoleSemaphorin-3ASemaphorinsSideSignal PathwaySignal TransductionSiteStrokeTestingTherapeuticTimeTissue SampleTubeVascularizationWestern Blottingadult neurogenesisangiogenesisaxon growthaxon guidanceaxonal pathfindingcell motilityfunctional restorationhealingimprovedin vivoinhibitor/antagonistinjuredmatrigelmetallothionein IIImouse modelneovascularizationneurogenesisneuron developmentneuronal growthnovel strategiespost strokepreventreceptorrelating to nervous systemrepairedspatiotemporalstroke recoverysynaptogenesis
项目摘要
DESCRIPTION (provided by applicant): After a stroke occurs, the brain up-regulates several repair pathways in an attempt to heal itself. One of the reasons for limited efficacy of this repair process lies in the presence of growth inhibitory factors in the injured region of the brain. Here, we propose to investigate the influence of signaling via the axon guidance molecule semaphorin 3A (Sema3A) on the recovery process after experimental stroke. Our hypothesis states that, analogous to its function in the developing brain, Sema3A acts as a repellent for growing axons and endothelial cells during adult neurogenesis and revascularization, and that this activity will be detrimental for the recovery process. Our pilot data suggest that i) Sema3A and its receptor neuropilin-1 (NRP-1), are up- regulated in the ischemic brain; ii) recombinant Sema3A leads to axon retraction in cultured cortical neurons, and inhibits tube formation in a brain endothelial cell line; and iii) Sema3A signaling can be disrupted by inhibition of 12/15-LOX. To expand these findings, we propose the following specific aims. In Aim 1, we use cultured primary neurons and a brain microvascular endothelial cell line to study the signaling pathways through which Sema3A operates. Both axonal pathfinding in neurons and development of new blood vessels following experimental stroke may be crucial for stroke recovery, and both are impacted by Sema3A. We will focus on signaling through the MAP kinase proteins, and on metabolites of 12/15-lipoxygenase, which have been shown to mediate the repulsive actions of Sema3A. In Aim 2, we study the expression of Sema3A and its receptor Neuropilin 1 (NRP1), in a mouse model of middle cerebral artery occlusion (MCAO). We will investigate differential effects of sema expression on neurogenesis-related axonal connectivity and the formation of brain microvessels, and correlate levels of Sema3A with functional recovery. In Aim 3, we inhibit axonal pathfinding of newly born neurons by injecting soluble semaphorin on the ipsilateral side of the brain subjected to MCAO. Alternatively, we disrupt semaphorin signaling by injecting an inhibitory peptoid, and by inhibiting the downstream mediator 12-lipoxygenase. Endogenous repair processes activated after stroke can potentially restore functionality to the damaged brain. Can manipulating the semaphorin pathway lead to more efficient integration of neurons and an improved revascularization? This application is relevant to PA-08-099 "Mechanisms of functional recovery after stroke".
描述(由申请人提供):中风发生后,大脑会上调多种修复途径以尝试自我治愈。这种修复过程功效有限的原因之一在于大脑受损区域中存在生长抑制因子。在这里,我们建议研究轴突引导分子信号蛋白 3A (Sema3A) 信号传导对实验性中风后恢复过程的影响。我们的假设表明,类似于其在发育中大脑中的功能,Sema3A 在成人神经发生和血运重建过程中充当轴突和内皮细胞生长的排斥剂,并且这种活性将不利于恢复过程。我们的试验数据表明 i) Sema3A 及其受体神经毡蛋白-1 (NRP-1) 在缺血性大脑中表达上调; ii) 重组 Sema3A 导致培养的皮质神经元中的轴突回缩,并抑制脑内皮细胞系中的管形成; iii) Sema3A 信号传导可通过抑制 12/15-LOX 来破坏。为了扩展这些发现,我们提出以下具体目标。在目标 1 中,我们使用培养的原代神经元和脑微血管内皮细胞系来研究 Sema3A 运作的信号通路。神经元的轴突寻路和实验性中风后新血管的发育可能对中风恢复至关重要,两者都受到 Sema3A 的影响。我们将重点关注通过 MAP 激酶蛋白的信号传导以及 12/15-脂氧合酶的代谢物,这些代谢物已被证明可以介导 Sema3A 的排斥作用。在目标 2 中,我们研究了大脑中动脉闭塞 (MCAO) 小鼠模型中 Sema3A 及其受体 Neuropilin 1 (NRP1) 的表达。我们将研究 sema 表达对神经发生相关的轴突连接和脑微血管形成的差异影响,并将 Sema3A 的水平与功能恢复相关联。在目标 3 中,我们通过在接受 MCAO 的大脑同侧注射可溶性信号蛋白来抑制新生神经元的轴突寻路。或者,我们通过注射抑制性肽并抑制下游介质 12-脂氧合酶来破坏信号蛋白信号传导。中风后激活的内源性修复过程有可能恢复受损大脑的功能。操纵信号蛋白通路能否导致神经元更有效的整合并改善血运重建?本申请与 PA-08-099“中风后功能恢复机制”相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KLAUS VAN LEYEN其他文献
KLAUS VAN LEYEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KLAUS VAN LEYEN', 18)}}的其他基金
Testing the Lipoxygenase Inhibitor BPN-27332 as Acute Phase Stroke Treatment in the SPAN Network
在 SPAN 网络中测试脂氧合酶抑制剂 BPN-27332 作为急性期中风治疗的作用
- 批准号:
10671991 - 财政年份:2023
- 资助金额:
$ 33.01万 - 项目类别:
A Novel Neuroprotectant to Reduce Ischemic Injury
一种减少缺血性损伤的新型神经保护剂
- 批准号:
10576568 - 财政年份:2023
- 资助金额:
$ 33.01万 - 项目类别:
Development of human 12/15-lipoxygenase therapeutics for stroke
开发人类 12/15-脂氧合酶治疗中风的药物
- 批准号:
9922389 - 财政年份:2018
- 资助金额:
$ 33.01万 - 项目类别:
Development of human 12/15-lipoxygenase therapeutics for stroke
开发人类 12/15-脂氧合酶治疗中风的药物
- 批准号:
9898504 - 财政年份:2018
- 资助金额:
$ 33.01万 - 项目类别:
Novel 12/15 lipoxygenase inhibitors for the treatment of stroke
用于治疗中风的新型 12/15 脂氧合酶抑制剂
- 批准号:
8684486 - 财政年份:2014
- 资助金额:
$ 33.01万 - 项目类别:
Novel 12/15 lipoxygenase inhibitors for the treatment of stroke
用于治疗中风的新型 12/15 脂氧合酶抑制剂
- 批准号:
8846695 - 财政年份:2014
- 资助金额:
$ 33.01万 - 项目类别:
Effects of Semaphorin 3A on Stroke Recovery
Semaphorin 3A 对中风恢复的影响
- 批准号:
8305479 - 财政年份:2011
- 资助金额:
$ 33.01万 - 项目类别:
Effects of Semaphorin 3A on Stroke Recovery
Semaphorin 3A 对中风恢复的影响
- 批准号:
8041869 - 财政年份:2011
- 资助金额:
$ 33.01万 - 项目类别:
12-Lipoxygenase and Ischemic Brain Cell Death
12-脂氧合酶和缺血性脑细胞死亡
- 批准号:
7404413 - 财政年份:2005
- 资助金额:
$ 33.01万 - 项目类别:
12/15-Lipoxygenase and neurovascular damage following cardiac arrest
心脏骤停后的 12/15-脂氧合酶和神经血管损伤
- 批准号:
8660352 - 财政年份:2005
- 资助金额:
$ 33.01万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
转录因子 RUNX1 单倍体缺陷中的人血小板缺陷
- 批准号:
10304868 - 财政年份:2013
- 资助金额:
$ 33.01万 - 项目类别:
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
转录因子 RUNX1 单倍体缺陷中的人血小板缺陷
- 批准号:
10083753 - 财政年份:2013
- 资助金额:
$ 33.01万 - 项目类别:
Effects of Semaphorin 3A on Stroke Recovery
Semaphorin 3A 对中风恢复的影响
- 批准号:
8305479 - 财政年份:2011
- 资助金额:
$ 33.01万 - 项目类别:
Effects of Semaphorin 3A on Stroke Recovery
Semaphorin 3A 对中风恢复的影响
- 批准号:
8041869 - 财政年份:2011
- 资助金额:
$ 33.01万 - 项目类别:
12/15-Lipoxygenase and neurovascular damage following cardiac arrest
心脏骤停后的 12/15-脂氧合酶和神经血管损伤
- 批准号:
8660352 - 财政年份:2005
- 资助金额:
$ 33.01万 - 项目类别: